ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Request New Study Section In Prevention And Control Of Chronic Disease

July 30, 1993

Seven Seats Open Up On NCAB

January 17, 1986

Report Finds NIH Not At Fault in Case Of P-32 Ingestion

September 26, 1997

New Chairman Of Core Grant Review Committee Has Some Advice for Applicants

May 5, 1978

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

Non-Adherence To Protocol Explains Outcome Differences In Hispanic Children With ALL

December 31, 2010